 | • レポートコード：GIR201115509 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、がん治療用遺伝子治療の世界市場を調査対象にし、がん治療用遺伝子治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（体細胞遺伝子治療（SCGT）、生殖細胞系遺伝子治療（GGT））、用途別分析（がん研究センター、診断研究所、がん病院、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Takara Bio、SynerGene Therapeutics、Cold Genesys、Tocagen、MultiVir、VBL Therapeutics、Anchiano Therapeutics、Momotaro-Gene、Genprex、Ziopharm Oncology、Celgene、Celsion、Bluebird Bio ・企業別売上、市場シェア ・がん治療用遺伝子治療の地域別市場分析 ・がん治療用遺伝子治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・がん治療用遺伝子治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・がん治療用遺伝子治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・がん治療用遺伝子治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・がん治療用遺伝子治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・がん治療用遺伝子治療の種類別市場規模2015-2020：体細胞遺伝子治療（SCGT）、生殖細胞系遺伝子治療（GGT） ・がん治療用遺伝子治療の用途別市場規模2015-2020：がん研究センター、診断研究所、がん病院、その他 ・がん治療用遺伝子治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Gene Therapies for Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gene Therapies for Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gene Therapies for Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gene Therapies for Cancer Treatment market has been segmented into:
Somatic Cell Gene Therapy (SCGT)
Germline Gene Therapy (GGT)
By Application, Gene Therapies for Cancer Treatment has been segmented into:
Cancer Research Centers
Diagnostic Laboratories
Cancer Hospitals
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Therapies for Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Therapies for Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Therapies for Cancer Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Gene Therapies for Cancer Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gene Therapies for Cancer Treatment Market Share Analysis
Gene Therapies for Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Therapies for Cancer Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Therapies for Cancer Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Gene Therapies for Cancer Treatment are:
Takara Bio
SynerGene Therapeutics
Cold Genesys
Tocagen
MultiVir
VBL Therapeutics
Anchiano Therapeutics
Momotaro-Gene
Genprex
Ziopharm Oncology
Celgene
Celsion
Bluebird Bio
1 Gene Therapies for Cancer Treatment Market Overview
1.1 Product Overview and Scope of Gene Therapies for Cancer Treatment
1.2 Classification of Gene Therapies for Cancer Treatment by Type
1.2.1 Global Gene Therapies for Cancer Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Type in 2019
1.2.3 Somatic Cell Gene Therapy (SCGT)
1.2.4 Germline Gene Therapy (GGT)
1.3 Global Gene Therapies for Cancer Treatment Market by Application
1.3.1 Overview: Global Gene Therapies for Cancer Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer Research Centers
1.3.3 Diagnostic Laboratories
1.3.4 Cancer Hospitals
1.3.5 Others
1.4 Global Gene Therapies for Cancer Treatment Market by Regions
1.4.1 Global Gene Therapies for Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gene Therapies for Cancer Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gene Therapies for Cancer Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Therapies for Cancer Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Therapies for Cancer Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gene Therapies for Cancer Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Therapies for Cancer Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takara Bio
2.1.1 Takara Bio Details
2.1.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takara Bio SWOT Analysis
2.1.4 Takara Bio Product and Services
2.1.5 Takara Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 SynerGene Therapeutics
2.2.1 SynerGene Therapeutics Details
2.2.2 SynerGene Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SynerGene Therapeutics SWOT Analysis
2.2.4 SynerGene Therapeutics Product and Services
2.2.5 SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cold Genesys
2.3.1 Cold Genesys Details
2.3.2 Cold Genesys Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cold Genesys SWOT Analysis
2.3.4 Cold Genesys Product and Services
2.3.5 Cold Genesys Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Tocagen
2.4.1 Tocagen Details
2.4.2 Tocagen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Tocagen SWOT Analysis
2.4.4 Tocagen Product and Services
2.4.5 Tocagen Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 MultiVir
2.5.1 MultiVir Details
2.5.2 MultiVir Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 MultiVir SWOT Analysis
2.5.4 MultiVir Product and Services
2.5.5 MultiVir Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 VBL Therapeutics
2.6.1 VBL Therapeutics Details
2.6.2 VBL Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 VBL Therapeutics SWOT Analysis
2.6.4 VBL Therapeutics Product and Services
2.6.5 VBL Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Anchiano Therapeutics
2.7.1 Anchiano Therapeutics Details
2.7.2 Anchiano Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Anchiano Therapeutics SWOT Analysis
2.7.4 Anchiano Therapeutics Product and Services
2.7.5 Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Momotaro-Gene
2.8.1 Momotaro-Gene Details
2.8.2 Momotaro-Gene Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Momotaro-Gene SWOT Analysis
2.8.4 Momotaro-Gene Product and Services
2.8.5 Momotaro-Gene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genprex
2.9.1 Genprex Details
2.9.2 Genprex Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genprex SWOT Analysis
2.9.4 Genprex Product and Services
2.9.5 Genprex Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ziopharm Oncology
2.10.1 Ziopharm Oncology Details
2.10.2 Ziopharm Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ziopharm Oncology SWOT Analysis
2.10.4 Ziopharm Oncology Product and Services
2.10.5 Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Celgene
2.11.1 Celgene Details
2.11.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Celgene SWOT Analysis
2.11.4 Celgene Product and Services
2.11.5 Celgene Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 Celsion
2.12.1 Celsion Details
2.12.2 Celsion Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Celsion SWOT Analysis
2.12.4 Celsion Product and Services
2.12.5 Celsion Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Bluebird Bio
2.13.1 Bluebird Bio Details
2.13.2 Bluebird Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Bluebird Bio SWOT Analysis
2.13.4 Bluebird Bio Product and Services
2.13.5 Bluebird Bio Gene Therapies for Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Therapies for Cancer Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Therapies for Cancer Treatment Players Market Share
3.2.2 Top 10 Gene Therapies for Cancer Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Regions
4.2 North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
5 North America Gene Therapies for Cancer Treatment Revenue by Countries
5.1 North America Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
5.2 USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
6 Europe Gene Therapies for Cancer Treatment Revenue by Countries
6.1 Europe Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
6.2 Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
6.4 France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries
7.1 Asia-Pacific Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
7.2 China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
7.5 India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
8 South America Gene Therapies for Cancer Treatment Revenue by Countries
8.1 South America Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
8.2 Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Gene Therapies for Cancer Treatment by Countries
9.1 Middle East & Africa Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gene Therapies for Cancer Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Gene Therapies for Cancer Treatment Market Forecast by Type (2019-2024)
10.3 Somatic Cell Gene Therapy (SCGT) Revenue Growth Rate (2015-2025)
10.4 Germline Gene Therapy (GGT) Revenue Growth Rate (2015-2025)
11 Global Gene Therapies for Cancer Treatment Market Segment by Application
11.1 Global Gene Therapies for Cancer Treatment Revenue Market Share by Application (2015-2020)
11.2 Gene Therapies for Cancer Treatment Market Forecast by Application (2019-2024)
11.3 Cancer Research Centers Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Cancer Hospitals Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Gene Therapies for Cancer Treatment Market Size Forecast (2021-2025)
12.1 Global Gene Therapies for Cancer Treatment Market Size Forecast (2021-2025)
12.2 Global Gene Therapies for Cancer Treatment Market Forecast by Regions (2021-2025)
12.3 North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
12.6 South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Gene Therapies for Cancer Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gene Therapies for Cancer Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Therapies for Cancer Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gene Therapies for Cancer Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takara Bio Corporate Information, Location and Competitors
Table 6. Takara Bio Gene Therapies for Cancer Treatment Major Business
Table 7. Takara Bio Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Takara Bio SWOT Analysis
Table 9. Takara Bio Gene Therapies for Cancer Treatment Product and Solutions
Table 10. Takara Bio Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. SynerGene Therapeutics Corporate Information, Location and Competitors
Table 12. SynerGene Therapeutics Gene Therapies for Cancer Treatment Major Business
Table 13. SynerGene Therapeutics Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2018-2019)
Table 14. SynerGene Therapeutics SWOT Analysis
Table 15. SynerGene Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 16. SynerGene Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Cold Genesys Corporate Information, Location and Competitors
Table 18. Cold Genesys Gene Therapies for Cancer Treatment Major Business
Table 19. Cold Genesys Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Cold Genesys SWOT Analysis
Table 21. Cold Genesys Gene Therapies for Cancer Treatment Product and Solutions
Table 22. Cold Genesys Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Tocagen Corporate Information, Location and Competitors
Table 24. Tocagen Gene Therapies for Cancer Treatment Major Business
Table 25. Tocagen Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Tocagen SWOT Analysis
Table 27. Tocagen Gene Therapies for Cancer Treatment Product and Solutions
Table 28. Tocagen Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. MultiVir Corporate Information, Location and Competitors
Table 30. MultiVir Gene Therapies for Cancer Treatment Major Business
Table 31. MultiVir Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 32. MultiVir SWOT Analysis
Table 33. MultiVir Gene Therapies for Cancer Treatment Product and Solutions
Table 34. MultiVir Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. VBL Therapeutics Corporate Information, Location and Competitors
Table 36. VBL Therapeutics Gene Therapies for Cancer Treatment Major Business
Table 37. VBL Therapeutics Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 38. VBL Therapeutics SWOT Analysis
Table 39. VBL Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 40. VBL Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Anchiano Therapeutics Corporate Information, Location and Competitors
Table 42. Anchiano Therapeutics Gene Therapies for Cancer Treatment Major Business
Table 43. Anchiano Therapeutics Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Anchiano Therapeutics SWOT Analysis
Table 45. Anchiano Therapeutics Gene Therapies for Cancer Treatment Product and Solutions
Table 46. Anchiano Therapeutics Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Momotaro-Gene Corporate Information, Location and Competitors
Table 48. Momotaro-Gene Gene Therapies for Cancer Treatment Major Business
Table 49. Momotaro-Gene Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Momotaro-Gene SWOT Analysis
Table 51. Momotaro-Gene Gene Therapies for Cancer Treatment Product and Solutions
Table 52. Momotaro-Gene Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Genprex Corporate Information, Location and Competitors
Table 54. Genprex Gene Therapies for Cancer Treatment Major Business
Table 55. Genprex Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Genprex SWOT Analysis
Table 57. Genprex Gene Therapies for Cancer Treatment Product and Solutions
Table 58. Genprex Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Ziopharm Oncology Corporate Information, Location and Competitors
Table 60. Ziopharm Oncology Gene Therapies for Cancer Treatment Major Business
Table 61. Ziopharm Oncology Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Ziopharm Oncology SWOT Analysis
Table 63. Ziopharm Oncology Gene Therapies for Cancer Treatment Product and Solutions
Table 64. Ziopharm Oncology Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Celgene Corporate Information, Location and Competitors
Table 66. Celgene Gene Therapies for Cancer Treatment Major Business
Table 67. Celgene Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Celgene SWOT Analysis
Table 69. Celgene Gene Therapies for Cancer Treatment Product and Solutions
Table 70. Celgene Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Celsion Corporate Information, Location and Competitors
Table 72. Celsion Gene Therapies for Cancer Treatment Major Business
Table 73. Celsion Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 74. Celsion SWOT Analysis
Table 75. Celsion Gene Therapies for Cancer Treatment Product and Solutions
Table 76. Celsion Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Bluebird Bio Corporate Information, Location and Competitors
Table 78. Bluebird Bio Gene Therapies for Cancer Treatment Major Business
Table 79. Bluebird Bio Gene Therapies for Cancer Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Bluebird Bio SWOT Analysis
Table 81. Bluebird Bio Gene Therapies for Cancer Treatment Product and Solutions
Table 82. Bluebird Bio Gene Therapies for Cancer Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Players (2015-2020)
Table 84. Global Gene Therapies for Cancer Treatment Revenue Share by Players (2015-2020)
Table 85. Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2015-2020)
Table 87. North America Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
Table 88. North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 89. Europe Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Gene Therapies for Cancer Treatment Revenue by Countries (2015-2020)
Table 92. South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Table 95. Global Gene Therapies for Cancer Treatment Revenue (Million USD) by Type (2015-2020)
Table 96. Global Gene Therapies for Cancer Treatment Revenue Share by Type (2015-2020)
Table 97. Global Gene Therapies for Cancer Treatment Revenue Forecast by Type (2021-2025)
Table 98. Global Gene Therapies for Cancer Treatment Revenue by Application (2015-2020)
Table 99. Global Gene Therapies for Cancer Treatment Revenue Share by Application (2015-2020)
Table 100. Global Gene Therapies for Cancer Treatment Revenue Forecast by Application (2021-2025)
Table 101. Global Gene Therapies for Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gene Therapies for Cancer Treatment Picture
Figure 2. Global Gene Therapies for Cancer Treatment Revenue Market Share by Type in 2019
Figure 3. Somatic Cell Gene Therapy (SCGT) Picture
Figure 4. Germline Gene Therapy (GGT) Picture
Figure 5. Gene Therapies for Cancer Treatment Revenue Market Share by Application in 2019
Figure 6. Cancer Research Centers Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Cancer Hospitals Picture
Figure 9. Others Picture
Figure 10. Global Gene Therapies for Cancer Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Gene Therapies for Cancer Treatment Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2019
Figure 19. Global Top 10 Players Gene Therapies for Cancer Treatment Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions (2015-2020)
Figure 23. Global Gene Therapies for Cancer Treatment Revenue Market Share by Regions in 2018
Figure 24. North America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Europe Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 27. South America Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 29. North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 30. North America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2019
Figure 31. USA Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Canada Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2019
Figure 36. Germany Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 37. UK Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 38. France Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Russia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Italy Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2019
Figure 43. China Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Japan Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Korea Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 46. India Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 48. South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 49. South America Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2019
Figure 50. Brazil Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 55. UAE Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Gene Therapies for Cancer Treatment Revenue and Growth Rate (2015-2020)
Figure 58. Global Gene Therapies for Cancer Treatment Revenue Share by Type (2015-2020)
Figure 59. Global Gene Therapies for Cancer Treatment Revenue Share by Type in 2019
Figure 60. Global Gene Therapies for Cancer Treatment Market Share Forecast by Type (2021-2025)
Figure 61. Global Somatic Cell Gene Therapy (SCGT) Revenue Growth Rate (2015-2020)
Figure 62. Global Germline Gene Therapy (GGT) Revenue Growth Rate (2015-2020)
Figure 63. Global Gene Therapies for Cancer Treatment Revenue Share by Application (2015-2020)
Figure 64. Global Gene Therapies for Cancer Treatment Revenue Share by Application in 2019
Figure 65. Global Gene Therapies for Cancer Treatment Market Share Forecast by Application (2021-2025)
Figure 66. Global Cancer Research Centers Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 68. Global Cancer Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Gene Therapies for Cancer Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Gene Therapies for Cancer Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Gene Therapies for Cancer Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 74. Europe Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 76. South America Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Gene Therapies for Cancer Treatment Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
遺伝子治療の世界市場 2020年 Market Overview The Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…- 遺伝子組み換え療法の世界市場 2020年 Market Overview The global Genetic Modification Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genetic Modifi…
- 子宮がん治療・診断の世界市場 2020年 Market Overview The global Uterine Cancer Therapies and Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uteri…
- 細胞及び遺伝子治療の世界市場 2020年 Market Overview The Cell and Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 遺伝子編集技術の世界市場 2020年 Market Overview The global Gene Editing Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Gene Editing Techno…